NCT07636590ClinicalTrials.gov
Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
A Multi-Center, Prospective, Non-Interventional Study in Subjects With Limbal Stem Cell Deficiency
בקצרה
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
תצפיתידרושים 500 משתתפים21 אתריםמדינה אחת
קטגוריות
רשום במרשם אחד
- ClinicalTrials.govNCT07636590פתיחת רשומה זו ב־ClinicalTrials.govסונכרן שלשום
מחקר יחיד יכול להיות רשום בכמה מרשמים. אנו מציגים אותו פעם אחת ומקשרים לכל רשומה שברשותנו.
מידע הניסוי מוצג כפי שפורסם על ידי המרשם, בשפת המקור שלו.
מתעניינים במחקר הזה?
התחברות או צרו חשבון כדי לרשום את התעניינותכם ולעקוב אחר המחקר הזה.
How this study is set up
The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.
- Not stated: Registered after enrolment began (about 18 days after the recorded start)First posted 2026-06-09; recorded start 2026-05-22
- Present: Has a defined primary outcomeA primary outcome measure is listed in the record
- Present: The primary outcome states a time frameThe primary outcome measure records a time frame
- Not stated: Whether participants are randomly assigned is not stated in the registry recordNo allocation method is recorded
- Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
- Not stated: Whether the study is blinded is not stated in the registry recordNo masking information is recorded
- Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
- Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
- Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
- Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
- Present: Sponsor has 2 other studies in this databaseCounted from the lead sponsor named in the record (Claris Biotherapeutics, Inc.)
- Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
- The record lists 1 condition.
- Lead sponsor type recorded as: industry.
Trial stature
Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.
An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.
How this score is built
- Randomised allocation0/20
Allocation not stated in the record
- Blinding0/20
Masking not stated in the record
- Control arm0/15
No comparator arm stated in the record
- Primary-outcome specificity10/10
Named primary outcome with a defined time frame
- Endpoint type3/10
Surrogate or intermediate endpoint (conservative default)
- Multi-centre5/8
Multi-centre: 2 sites
- Data monitoring committee0/7
No data monitoring committee stated
- Prospective registration3/5
Registered within 30 days of the study start
- Protocol / SAP posted0/5
No protocol or SAP posted to the registry
A medium-sized study: 500 participants (target), run at 21 sites.
How this score is built
- Enrolment26/40
500 participants (target)
- Site count4/25
2 sites
- Country count0/15
Single country
- Planned duration7/10
Planned over about 22 months
- Sponsor scale1/10
Claris Biotherapeutics, Inc. has led 3 trials in our corpus
We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.
How this score is built
- Investigator standing0/100
No investigator recorded in the registry for this trial
These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.
תקציר
The goal of this non-interventional, observational study is to describe the natural history, clinical course, and management patterns of subjects with limbal stem cell deficiency (LSCD).
מצבים רפואיים
- Limbal Stem Cell Deficiency
זכאות
| מין | הכול |
|---|---|
| גילאים | 12 Years – 99 Years |
| מתנדבים בריאים | לא |
| שיטת דגימה | PROBABILITY_SAMPLE |
אוכלוסיית המחקר
Adult and adolescent subjects with qualifying LSCD
זכאות כפי שנכתבה במרשם
זכאות במשפטים פשוטים
הקריטריונים של רשומה זו טרם פורקו למשפטים נפרדים. טקסט המרשם שלמעלה שלם והוא הגרסה המחייבת.
תכנון המחקר
| סוג המחקר | תצפיתי |
|---|---|
| שלב | לא צוין ברשומת המרשם |
| הקצאה | לא צוין ברשומת המרשם |
| מודל ההתערבות | לא צוין ברשומת המרשם |
| מטרה ראשית | לא צוין ברשומת המרשם |
| הסתרה | לא צוין ברשומת המרשם |
| גיוס | דרושים 500 משתתפים |
נותן חסות ושותפים
- Claris Biotherapeutics, Inc. נותן חסות
זרועות והתערבויות
- Non-interventional
No product administration.
התערבויות
- אחר Non-interventional
Non-interventional
מדדי תוצאה
מדד תוצאה ראשוני
Natural Progression of LSCD as Assessed by Changes in Patient Reported Outcomes
Onset or changes (worsening or improving) in vision-related quality of life and ocular symptoms as captured with the National Eye Institute Visual Function Questionnaire-25 (VFQ-25) and Ocular Surface Disease Index (OSDI) questionnaires
מסגרת זמן Screening through Week 84
מדד תוצאה ראשוני
Natural Progression of LSCD as Assessed by Functional Changes (Photophobic BCVA)
Change in photophobic BCVA
מסגרת זמן Screening through Week 84
מדד תוצאה ראשוני
Natural Progression of LSCD as Assessed by Functional Changes (Low-luminance BCVA)
Change in low-luminance BCVA
מסגרת זמן Screening through Week 84
מדד תוצאה ראשוני
Natural Progression of LSCD as Assessed by Functional Changes (Low-contrast BCVA)
Change in low-contrast BCVA
מסגרת זמן Screening through Week 84
מדד תוצאה ראשוני
Natural Progression of LSCD as Assessed by Functional Changes (Contrast Sensitivity)
Change in contrast sensitivity (Pelli-Robson)
מסגרת זמן Screening through Week 84
מדד תוצאה ראשוני
Natural Progression of LSCD as Assessed by Anatomical/Structural Changes
Change in area of central cornea conjunctivalization
מסגרת זמן Screening through Week 84
מדד תוצאה משני
Changes that May be Correlated with LSCD as Assessed by Functional Changes (Corneal Sensitivity)
Changes (onset, improvement, or worsening) in corneal sensitivity
מסגרת זמן Screening through Week 84
מדד תוצאה משני
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Corneal Topography/Tomography)
Changes (onset, improvement, or worsening) in corneal topography and/or tomography and/or densitometry
מסגרת זמן Screening through Week 84
מדד תוצאה משני
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial Defect Frequency)
Changes (onset, improvement, or worsening) in epithelial defect frequency
מסגרת זמן Screening through Week 84
מדד תוצאה משני
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Palisades of Vogt Crypts)
Changes (onset, improvement, or worsening) in Palisades of Vogt crypts
מסגרת זמן Screening through Week 84
מדד תוצאה משני
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Epithelial and Total Corneal Thickness)
Changes (onset, improvement, or worsening) in epithelial and total corneal thickness
מסגרת זמן Screening through Week 84
מדד תוצאה משני
Changes that May be Correlated with LSCD as Assessed by Anatomical Changes (Pannus)
Changes (onset, improvement, or worsening) in pannus
מסגרת זמן Screening through Week 84
מדד תוצאה משני
Changes that May be Correlated with LSCD as Assessed by Changes Ocular and Systemic Health Outcome Measures
Changes (onset, improvement/resolution, or worsening) of an existing condition
מסגרת זמן Screening through Week 84
תאריכים
| תאריך התחלה | 22 במאי 2026 (בפועל) |
|---|---|
| סיום ראשוני | 1 במרץ 2028 (משוער) |
| סיום | 1 במרץ 2028 (משוער) |
| פורסם לראשונה | 9 ביוני 2026 (בפועל) |
| עודכן לאחרונה | 18 בנובמבר 2026 |
| התוצאות פורסמו | לא צוין ברשומת המרשם |
| המצב אומת לאחרונה | נובמבר 2026 |
בפועל פירושו שהאירוע התרחש. משוער פירושו שנותן החסות צופה אותו. שתי המשמעויות שונות זו מזו.
מיקומים
21 אתרים מגייסים
United States
| מתקן | עיר | מדינה או אזור | מצב |
|---|---|---|---|
| Claris Investigative Site | Carmel | Indiana | מגייס |
| Claris Investigative Site | Cranberry Township | Pennsylvania | מגייס |
| Claris Investigative Site | Draper | Utah | מגייס |
| Claris Investigative Site | Huntington Beach | California | מגייס |
| Claris Investigative Site | Indianapolis | Indiana | מגייס |
| Claris Investigative Site | Kansas City | Missouri | מגייס |
| Claris Investigative Site | La Jolla | California | מגייס |
| Claris Investigative Site | Los Angeles | California | מגייס |
| Claris Investigative Site | Louisville | Kentucky | מגייס |
| Claris Investigative Site | Minnetonka | Minnesota | מגייס |
| Claris Investigative Site | Norfolk | Virginia | מגייס |
| Claris Investigative Site | Overland Park | Kansas | מגייס |
| Claris Investigative Site | Palisades Park | New Jersey | מגייס |
| Claris Investigative Site | Portland | Oregon | מגייס |
| Claris Investigative Site | Rockville Centre | New York | מגייס |
| Claris Investigative Site | San Antonio | Texas | מגייס |
| Claris Investigative Site | Sioux Falls | South Dakota | מגייס |
| Claris Investigative Site | Smyrna | Tennessee | מגייס |
| Claris Investigative Site | South Dartmouth | Massachusetts | מגייס |
| Claris Investigative Site | Tampa | Florida | מגייס |
| Claris Investigative Site | Wichita | Kansas | מגייס |
מסמכי המחקר
לא צורפו מסמכים ברשומת מרשם זו.
שינויים לאורך זמן
- 18 בנובמבר 2026
אתר נוסף
13 sites added (21 total)
821
- 6 באוגוסט 2026
אתר נוסף
6 sites added (8 total)
28